-
Mashup Score: 10Donate - RIP Medical Debt - 1 year(s) ago
End Medical Debt 64 million indebted Americans struggle to keep their heads above water. You can help them today.
Source: ripmedicaldebt.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Abstracts & Posters | ASCO Annual Meeting - 2 year(s) ago
Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with…
Source: conferences.asco.orgCategories: Latest Headlines, UrologyTweet-
Heading to #ASCO23? Want to get a head start on meeting content on your flight to Chicago? The @ASCO website is mostly organized w hyperlinks, but you can download by track ahead of time and review the abstracts wout wifi here: https://t.co/R4k85fcfNW…See everyone soon!
-
-
Mashup Score: 02023 Walk to End Bladder Cancer - Philadelphia: Fox Chase Cancer Center - Bladder Cancer Advocacy Network - 2 year(s) ago
Join us at a 2023 Walk to End Bladder Cancer.
Source: secure2.convio.netCategories: Hem/Oncs, Latest HeadlinesTweet-
It's not too late to donate! Here's the link: https://t.co/swVi4PAqFC https://t.co/E1LUfl6iIT
-
-
Mashup Score: 0
Abstract. Purpose: Based on preclinical evidence of epigenetic contribution to sensitivity and resistance to immune checkpoint inhibitors (ICI), we hypothesized that guadecitabine (hypomethylating agent) and atezolizumab (anti-PD-L1) together would potentiate a clinical response in patients with metastatic urothelial carcinoma (UC) unresponsive to initial immune checkpoint blockade therapy….
Categories: Latest Headlines, UrologyTweet-
6y ago @AACR headquarters we faced this panel competing for @SU2C @Genentech catalyst award for our #bladdercancer trial. Thank you for funding us! Our teams @VAInstitute @FoxChaseCancer completed the trial and results are now published in @CCR_AACR https://t.co/bkAXpJbaKF https://t.co/WYc2c7eSKk
-
-
Mashup Score: 0Nomograms | Cancer Prediction Tools | Fox Chase Cancer Center - 2 year(s) ago
CancerNomograms is a project of Fox Chase Cancer Center which seeks to be the preeminent source of implementations of the most current and cutting-edge predictive nomograms and other patient health and evaluative models available for a multitude of disease sites. The site currently contains web-based implementations of nomograms and models for Kidney, Prostate…
Source: cancernomograms.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Great tool to help estimate risk of recurrence at the patient level: the ASSURE nomogram operationalized by @UroCorrea at https://t.co/hiKarRQ8Aa
-
-
Mashup Score: 1Nomograms | Cancer Prediction Tools | Fox Chase Cancer Center - 2 year(s) ago
CancerNomograms is a project of Fox Chase Cancer Center which seeks to be the preeminent source of implementations of the most current and cutting-edge predictive nomograms and other patient health and evaluative models available for a multitude of disease sites. The site currently contains web-based implementations of nomograms and models for Kidney, Prostate…
Source: cancernomograms.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @scientistatlrge: @MattZibelman breaks down adjuvant in RCC. What to do when Rx decision making is hard? Use https://t.co/Sa0hfFP0EX dev…
-
-
Mashup Score: 18Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer - 2 year(s) ago
Urothelial Cancer – Genomic Analysis to Improve Patient Outcomes and Research (NCT02643043), UC-GENOME, is a genomic analysis and biospecimen repository study in 218 patients with metastatic urothelial carcinoma. Here we report on the primary outcome of the UC-GENOME—the proportion of subjects who received next generation sequencing (NGS) with treatment options—and present the initial genomic…
Source: www.nature.comCategories: Latest Headlines, Oncologists1Tweet-
RT @MattMilowsky: Excited to share @BladderCancerUS UC-GENOME genomic and biospecimen study in #bladdercancer https://t.co/kqWxHgyrjc @Will…
-
RT @MattMilowsky: Excited to share @BladderCancerUS UC-GENOME genomic and biospecimen study in #bladdercancer https://t.co/kqWxHgyrjc @Will…
-
RT @MattMilowsky: Excited to share @BladderCancerUS UC-GENOME genomic and biospecimen study in #bladdercancer https://t.co/kqWxHgyrjc @Will…
-
-
Mashup Score: 3Women Who Conquer Cancer - 2 year(s) ago
Thank You for Supporting Female Oncologists! We are currently raising funds for the 2023 Women Leaders of Oncology Women Who Conquer Cancer Young Investigator Award. All additional funds will go toward our goal of raising $1.35 million for the Conquer Cancer-Women Leaders in Oncology Young Investigator Award Endowment. This will help ensure that female scientists can receive annual…
Source: fundraise.givesmart.comCategories: Hem/Oncs, Latest HeadlinesTweet-
So great to hear from and congratulate @SusanScottMD @HopkinsMedicine and her work in #lungcancer funded by the 2022 WLO Women Who Conquer Cancer Young Investigator Award (YIA), To donate to fund the endowment that supports future awards: https://t.co/La0fTcZzKt https://t.co/T0GB60ZFVA
-
-
Mashup Score: 1
Responses to rejection vary considerably, and negative responses can lead promising individuals to abandon careers in academic medicine. Resilience does not, however, seem to be immutable-It can be learned. Given the frequency of experiences with rejection in academic medicine, strategies such as tr …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
🔥 @reshmajagsi shares wisdom: embrace serindipity, build a mentor network that includes sponsors and peers, negotiate, build resilience, do what you love and delegate the rest wisely! #LEAD2022 And if you read only one of her papers: https://t.co/csVbszeNAS https://t.co/3rQxzu7ZlC
-
-
Mashup Score: 4Fox Chase researchers win $1.4M DoD Prostate Cancer Health Equity Grant - The Cancer Letter - 3 year(s) ago
A team of researchers at Fox Chase Cancer Center was awarded a Department of Defense Prostate Cancer Health Disparity Research Award for New Investigators. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log […]
Source: The Cancer LetterCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @TheCancerLetter: .@FoxChaseCancer researchers win $1.4M DoD Prostate Cancer Health Equity Grant. https://t.co/8GkPlY22Xl https://t.co/i…
-
Another great organization to donate to this holiday season: @ripmedicaldebt each donation abolishes $100 in medical debt for every $1 donated. Pretty good return on investment https://t.co/yYivazuvL5